SR-THAP
SR-THAP is a γ-aminobutyric acid transporter 3 (GAT3) inhibitor with an IC50 of 4.9 μM, and exhibits 42-fold and 23-fold selectivity over GAT1 and GlyT1, respectively. SR-THAP inhibits GABA uptake in mammalian cells. SR-THAP is applicable to the research of epilepsy, Alzheimer's disease and ischemic stroke.
Nos produits utilisent uniquement pour la recherche. Nous ne vendons pas aux patients.
- CAS No.: 3098361-74-8
- Formule: C31H35NO6
- Masse moléculaire:517.61
-
Stockage:
Please store the product under the recommended conditions in the Certificate of Analysis.
Activité biologique
Description
In Vitro
SR-THAP (0-1000 μM; 120 min preincubation + 3 min uptake) inhibits hGAT3C316S mutant-mediated [3H]GABA uptake in HEK293T cells with reduced potency (IC50 = 10.6 μM) compared to wild-type hGAT3[1].
MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.
Chemical Information
-
CAS No. 3098361-74-8
-
Masse moléculaire 517.61
-
Formule C31H35NO6
-
SMILES
COC1=CC=C(C=C1)C(C2=CC=C(C=C2)OC)(C3=CC=C(C=C3)OC)/C=C/CN4CCC[C@]4([H])[C@@H](C(O)=O)O
-
Livraison
Room temperature in continental US; may vary elsewhere.
-
Stockage
Please store the product under the recommended conditions in the Certificate of Analysis.
Pureté et documentation
Références
Calculators
Concentration (start) × Volume (start) = Concentration (final) × Volume (final)